Phase I trial of weekly trabectedin (ET-743) and gemcitabine in patients with advanced solid tumors

Title
Phase I trial of weekly trabectedin (ET-743) and gemcitabine in patients with advanced solid tumors
Authors
Keywords
-
Journal
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 63, Issue 1, Pages 181-188
Publisher
Springer Nature
Online
2008-03-31
DOI
10.1007/s00280-008-0733-7

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search